Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 425658

Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma


Hrvačić, Boška; Bošnjak, Berislav; Bosnar, Martina; Ferenčić, Željko; Glojnarić, Ines; Eraković Haber, Vesna
Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma // European journal of pharmacology, 616 (2009), 1/3; 236-243 doi:10.1016/j.ejphar.2009.06.032 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 425658 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma

Autori
Hrvačić, Boška ; Bošnjak, Berislav ; Bosnar, Martina ; Ferenčić, Željko ; Glojnarić, Ines ; Eraković Haber, Vesna

Izvornik
European journal of pharmacology (0014-2999) 616 (2009), 1/3; 236-243

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
airway hyperresponsiveness; asthma; clarithromycin; inflammation; mouse

Sažetak
Macrolide antibiotics, a class of potent antimicrobials, also possess immunomodulatory/anti-inflammatory properties. These properties are considered fundamental for the efficacy of macrolide antibiotics in the treatment of diffuse panbronchiolitis and cystic fibrosis. In patients with asthma, macrolide antibiotics have been reported to reduce airway hyperresponsiveness and improve pulmonary function. However, their beneficial actions in asthmatics possibly could be attributed to antimicrobial activity against atypical pathogens (e.g. Chlamydia pneumoniae), corticosteroid-sparing effect (inhibition of exogenous corticosteroid metabolism), and/or their anti-inflammatory/immunomodulatory effects. In order to investigate whether efficacy of macrolide antibiotics in asthma results from their immunomodulatory/anti-inflammatory activity, the influence of clarithromycin pretreatment (2 h before challenge) was examined on ovalbumin-induced airway hyperresponsiveness and airway inflammation in the mouse. Clarithromycin treatment (200 mg/kg intraperitoneally) decreased IL-4, IL-5, IL-13, CXCL2 and CCL2 concentrations in bronchoalveolar lavage fluid and markedly reduced inflammatory cell accumulation in bronchoalveolar lavage fluid and into the lungs, as revealed by histopathological examination. Furthermore, clarithromycin-induced reduction in inflammation was accompanied by normalization of airway hyperresponsiveness. In summary, in ovalbumin-induced mouse models, clarithromycin efficiently inhibited two important pathological characteristics of asthma, airway hyperresponsiveness and inflammation. These data suggest that the efficacy of clarithromycin, as well as of other macrolide antibiotics, in asthmatic patients could be attributed to their anti-inflammatory/ immunomodulatory properties, and not only to their antimicrobial activity or exogenous corticosteroidsparing effects.

Izvorni jezik
Engleski

Znanstvena područja
Biologija



POVEZANOST RADA


Ustanove:
Fidelta d.o.o.

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com ac.els-cdn.com

Citiraj ovu publikaciju:

Hrvačić, Boška; Bošnjak, Berislav; Bosnar, Martina; Ferenčić, Željko; Glojnarić, Ines; Eraković Haber, Vesna
Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma // European journal of pharmacology, 616 (2009), 1/3; 236-243 doi:10.1016/j.ejphar.2009.06.032 (međunarodna recenzija, članak, znanstveni)
Hrvačić, B., Bošnjak, B., Bosnar, M., Ferenčić, Ž., Glojnarić, I. & Eraković Haber, V. (2009) Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma. European journal of pharmacology, 616 (1/3), 236-243 doi:10.1016/j.ejphar.2009.06.032.
@article{article, author = {Hrva\v{c}i\'{c}, Bo\v{s}ka and Bo\v{s}njak, Berislav and Bosnar, Martina and Feren\v{c}i\'{c}, \v{Z}eljko and Glojnari\'{c}, Ines and Erakovi\'{c} Haber, Vesna}, year = {2009}, pages = {236-243}, DOI = {10.1016/j.ejphar.2009.06.032}, keywords = {airway hyperresponsiveness, asthma, clarithromycin, inflammation, mouse}, journal = {European journal of pharmacology}, doi = {10.1016/j.ejphar.2009.06.032}, volume = {616}, number = {1/3}, issn = {0014-2999}, title = {Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma}, keyword = {airway hyperresponsiveness, asthma, clarithromycin, inflammation, mouse} }
@article{article, author = {Hrva\v{c}i\'{c}, Bo\v{s}ka and Bo\v{s}njak, Berislav and Bosnar, Martina and Feren\v{c}i\'{c}, \v{Z}eljko and Glojnari\'{c}, Ines and Erakovi\'{c} Haber, Vesna}, year = {2009}, pages = {236-243}, DOI = {10.1016/j.ejphar.2009.06.032}, keywords = {airway hyperresponsiveness, asthma, clarithromycin, inflammation, mouse}, journal = {European journal of pharmacology}, doi = {10.1016/j.ejphar.2009.06.032}, volume = {616}, number = {1/3}, issn = {0014-2999}, title = {Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma}, keyword = {airway hyperresponsiveness, asthma, clarithromycin, inflammation, mouse} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font